Condition
Upper Trapezius Trigger Points
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed3
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07260019Not ApplicableNot Yet RecruitingPrimary
INSTRUMENT ASSISSTED SOFT TISSUE MOBILIZATION VERSUS DRY CUPPING ON UPPER TRAPEZIUS TRIGGER POINTS: A RANDOMIZED CONTROLLED TRIAL
NCT07058636Not ApplicableRecruiting
Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain
NCT05275634Not ApplicableCompletedPrimary
Interferential Current And Trapezius Myofascial Trigger Points
NCT05415813Not ApplicableCompletedPrimary
Effects of IC With and Without MET on Upper Trapezius Trigger Points
NCT05187468Not ApplicableCompleted
The Effectiveness of Radial ESWT on Upper Trapezius Mtrps
Showing all 5 trials